Formation of ondansetron polymorphs

International Journal of Pharmaceutics

Volumn 177, Issue 2, 1999, Pages 221-229

  Llacer J M ^a   Gallardo, V ^a   Parera, A ^a   Ruiz, M A ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

1H nuclear magnetic resonance; Differential scanning calorimetry; Infrared spectroscopy; Ondansetron; Polymorphism

Indexed keywords

ANTIEMETIC AGENT; ONDANSETRON;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; INFRARED SPECTROPHOTOMETRY; INFRARED SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ANTIEMETICS; CALORIMETRY, DIFFERENTIAL SCANNING; ETHANOL; HEAT; HYDROGEN-ION CONCENTRATION; MAGNETIC RESONANCE IMAGING; METHANOL; ONDANSETRON; SOLVENTS; SPECTROPHOTOMETRY, INFRARED;

EID: 0344958802     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(98)00349-4     Document Type: Article

References (13)

1. Blackwell C.P., Harding S.M. The clinical pharmacology of ondansetron. Eur. J. Cancer Clin. Oncol. 25(suppl. 1):1989;21-24.
2. Brittain H.G., Morris K.R., Bugay D.E., Thakur A.B., Serajuddin A.T. Solid-state NMR and IR for the analysis of pharmaceutical solids: polimorphs of fosinopril sodium. J. Pharm. Biomed. Anal. 11(11-12):1993;1063-1069.
3. Freeman A.J. et al. Selectivity of 5-HT3 receptor antagonist and anti-emetic mechanisms of action. Anti-cancer Drugs. 3:1991;79-85.
4. Haleblian J., McCrone W. Pharmaceutical applications of polymorphism. J. Pharm. Sci. 8:1969;918.
5. Helman J. Pharmacotecnia teórica y práctica. 1980;1139-1143 Continental, Mexico D.F.
6. Merck Index, 1996. 20th ed. Merck & Co., Rahway, NJ, p. 6977.
7. Otsuka M., Matsuda Y. Polymorphism: Pharmaceutical aspects. Gennaro A.R. et al. Remington Pharmacia, Editorial Médica Panamericana. 17th ed. 1987;1912 Buenos Aires.
8. Pritchard J.F. Ondansetron metabolism and pharmacokinetics. Semin. Oncol. 19(suppl. 19):1992;9-15.
9. Ravin L.T. Preformulation. Swarbick J., Boyland J.C. Encyclopedia of Pharmaceutical Technology. 12:1995;305-325 Marcel Dekker, New York.
10. Roita F., Del Favero A. Ondansetron clinical pharmacokinetics. Clin. Pharmacokinetics. 29(2):1995;94-108.
11. Ruiz M.A., Ismail I., Gallardo V., Delgado A.V. Application of differential scanning calorimetry to the study of latex stability. Thermochim. Acta. 247:1994;369-375.
12. Ruiz M.A., Gallardo V., Reyes I., Vera P., Delgado A.V. Stability of cellulose acetophthalate latex. Thermochim. Acta. 313:1998;145-154.
13. 2H NMR study on alteration of the membrane organization of mouse B16 melanoma cells treated with 12-O-tetradecanoylpho rbol-13-acetate. J. Biochem. (Tokyo). 100(4):1986;867-874.